{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"id":[{"id":"https:\/\/ror.org\/02twcfp32","id-type":"ROR","asserted-by":"publisher"}]}],"indexed":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T11:10:24Z","timestamp":1726571424702},"reference-count":0,"publisher":"Society of Psychoceramics","content-domain":{"domain":[]},"short-container-title":[],"published-print":{"date-parts":[[2016,8,19]]},"DOI":"10.32013\/uzzxuo4","type":"peer-review","created":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T19:29:08Z","timestamp":1626809348000},"source":"Crossref","is-referenced-by-count":0,"title":["Review: Treatment of plaque psoriasis with an ointment formulation of the Januskinase inhibitor, tofacitinib: a Phase 2b randomized clinical trial. V1"],"prefix":"10.32013","author":[{"given":"Wilson","family":"Smith","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02twcfp32","id-type":"ROR","asserted-by":"publisher"},{"id":"https:\/\/www.isni.org\/0000000405062673","id-type":"ISNI","asserted-by":"publisher"},{"id":"https:\/\/www.wikidata.org\/entity\/Q5188229","id-type":"wikidata","asserted-by":"publisher"}],"department":["Feline Outreach"]},{"id":[{"id":"https:\/\/ror.org\/01bj3aw27","id-type":"ROR","asserted-by":"publisher"}]}]}],"member":"17333","container-title":[],"review":{"running-number":"RC1","revision-round":"1","stage":"pre-publication","competing-interest-statement":"There were no competing interests","recommendation":"accept"},"original-title":[],"deposited":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T10:40:52Z","timestamp":1726569652000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.crossref.org\/xml-samples"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,19]]},"references-count":0,"URL":"https:\/\/doi.org\/10.32013\/uzzxuo4","relation":{"is-review-of":[{"id-type":"doi","id":"10.32013\/12345678","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2016,8,19]]}}}